Why the study?
Tricuspid transcatheter edge-to-edge repair (T-TEER) is a promising therapy for tricuspid regurgitation, but data in Asia using a dedicated system remain scarce.
Does tricuspid transcatheter edge-to-edge repair (T-TEER) improve early clinical and echocardiographic outcomes in Asian patients with tricuspid regurgitation?
Does tricuspid transcatheter edge-to-edge repair (T-TEER) improve early clinical and echocardiographic outcomes in Asian patients with tricuspid regurgitation?
This study reports early clinical and echocardiographic outcomes of tricuspid transcatheter edge-to-edge repair in an Asian cohort.
Supports feasibility in Asian patients; extends Western data but remains hypothesis-generating pending RCTs.
ricuspid transcatheter edge-to-edge repair (T-TEER) is a promising therapy for tricuspid regurgitation (TR). 1-3 T-TEER data in Asia with a dedicated system remain scarce. 4 We report a retrospective single-center observational study of patients who underwent T-TEER with TriClip or MitraClip (Abbott) using the “miskey” technique in Hong Kong.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: